See also this year's filing and all EDGAR filings for this company.
PDF Report 0001436304_2015_Kythera_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Epirus Biopharmaceuticals Inc', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Alder Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001436304, Kythera Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,159,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,847,000 |
| 3 | remainder_Assets | 420,000 |
| 4 | LiabilitiesCurrent | 20,629,000 |
| 5 | LiabilitiesNoncurrent | 698,000 |
| 6 | remainder_Liabilities | 22,661,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,055,000 |
| 9 | ResearchAndDevelopmentExpense | 47,840,000 |
| 10 | remainder_Expenses | 56,914,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 188,000 |
| 13 | remainder_ComprehensiveNetIncome | -57,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 103,426,000 |
| 1 | Liabilities | 43,988,000 |
| 2 | Expenses | 135,809,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 59,438,000 |
| 5 | NetIncome | -135,621,000 |
| 6 | ComprehensiveNetIncome | -135,649,500 |
| 7 | BaseVar | 141,734,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.0824 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
